A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST) (NCT06630234)
A Master Protocol for the Multi-cohort, Open-label, Phase 1/2 Study of DCC-3009 in Participants With Gastrointestinal Stromal Tumor (GIST)
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this Phase 1/2 master protocol study is to evaluate if DCC-3009 is safe, tolerable and works effectively in the treatment of GIST. The study will use a modular approach with each module being defined according to therapy: DCC-3009 alone or DCC-3009 in combination with other anticancer therapies. Each module will be conducted in 2 parts: Part 1 (Dose Escalation) and Part 2 (Dose Expansion). Participants will be treated in 28-day treatment cycles with an estimated duration of up to 2 years.
Who can join: Review the eligibility criteria below.
Location: HonorHealth — Scottsdate, Arizona
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (10 Sites)
- HonorHealth — Scottsdate, Arizona
- UC San Diego Moores Cancer Center — La Jolla, California
- University of Colorado Anschutz Medical Campus — Aurora, Colorado
- Mayo Clinic Florida — Jacksonville, Florida
- University of Miami - Sylvester Comprehensive Cancer Center — Miami, Florida
- Dana Farber Cancer Institute — Boston, Massachusetts
- START Midwest — Grand Rapids, Michigan
- Mayo Clinic Rochester — Rochester, Minnesota
- Memorial Sloan Kettering Cancer Center — New York, New York
- Vanderbilt University-Ingram Cancer Center — Nashville, Tennessee
📞 Contact the Study Coordinator
Phone: (888) 724-3274
Email: clinicaltrials@deciphera.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Gastrointestinal Stromal Tumor (GIST)
Explore by condition: All Gastrointestinal Stromal Tumor (GIST) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.